AdaptHealth Corp (NASDAQ: AHCO) stock jumped 3.02% on Friday to $8.53 against a previous-day closing price of $8.28. With 1.09 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.44 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $8.68 whereas the lowest price it dropped to was $8.37. The 52-week range on AHCO shows that it touched its highest point at $23.00 and its lowest point at $6.37 during that stretch. It currently has a 1-year price target of $11.50. Beta for the stock currently stands at 0.86.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AHCO was up-trending over the past week, with a rise of 23.98%, but this was up by 10.78% over a month. Three-month performance dropped to -24.98% while six-month performance fell -22.74%. The stock lost -60.33% in the past year, while it has lost -55.62% so far this year. A look at the trailing 12-month EPS for AHCO yields -3.35 with Next year EPS estimates of 0.77. For the next quarter, that number is 0.19. This implies an EPS growth rate of 5.74% for this year and 2.78% for next year.
Float and Shares Shorts:
At present, 134.44 million AHCO shares are outstanding with a float of 71.39 million shares on hand for trading. On Oct 30, 2023, short shares totaled 8.12 million, which was 6.02% higher than short shares on Sep 28, 2023. In addition to AGCO as the firm’s AGCO Corporation, ARCO serves as its Arcos Dorados Holdings Inc..
Through their ownership of 91.04% of AHCO’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 55.09% of AHCO, in contrast to 32.98% held by mutual funds. Shares owned by individuals account for 24.85%. As the largest shareholder in AHCO with 8.87% of the stake, BlackRock Fund Advisors holds 12,077,860 shares worth 12,077,860. A second-largest stockholder of AHCO, The Vanguard Group, Inc., holds 8,401,923 shares, controlling over 6.17% of the firm’s shares. Fidelity Management & Research Co is the third largest shareholder in AHCO, holding 7,108,460 shares or 5.22% stake. With a 4.05% stake in AHCO, the iShares Core S&P Small Cap ETF is the largest stakeholder. A total of 5,513,173 shares are owned by the mutual fund manager. The Fidelity Value Fund, which owns about 1.84% of AHCO stock, is the second-largest Mutual Fund holder. It holds 2,505,896 shares valued at 18.37 million. Vanguard Total Stock Market ETF holds 1.72% of the stake in AHCO, owning 2,337,979 shares worth 17.14 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AHCO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AHCO analysts setting a high price target of $16.00 and a low target of $6.50, the average target price over the next 12 months is $11.50. Based on these targets, AHCO could surge 87.57% to reach the target high and fall by -23.8% to reach the target low. Reaching the average price target will result in a growth of 34.82% from current levels.
Summary of Insider Activity:
Insiders traded AHCO stock several times over the past three months with 2 Buys and 1 Sells. In these transactions, 36,589 shares were bought while 6,908 shares were sold. The number of buy transactions has increased to 22 while that of sell transactions has risen to 44 over the past year. The total number of shares bought during that period was 1,448,884 while 8,555,505 shares were sold.